Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease
Brain Sciences · 12.05.2023 · 13 (5) · 790
DOI: 10.3390/brainsci13050790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 12.05.2023. Verfasst von Wei Quan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegeneration and Injury, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, Postgraduate Research & Practice Innovation Program of Jiangsu Province, Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (Originalsprache)
Observational studies have shown abnormal changes in trimethylamine N-oxide (TMAO) levels in the peripheral circulatory system of Parkinson’s disease (PD) patients. TMAO is a gut microbiota metabolite that can cross the blood–brain barrier and is strongly related to neuroinflammation. Neuroinflammation is one of the pathological drivers of PD. Herein, we investigated the effect of TMAO on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model mice. TMAO pretreatment was given by adding 1.5% (w/v) TMAO to the drinking water of the mice for 21 days; then, the mice were administered MPTP (20 mg/kg, i.p.) four times a day to construct an acute PD model. Their serum TMAO concentrations, motor function, dopaminergic network integrity, and neuroinflammation were then assayed. The results showed that TMAO partly aggravated the motor dysfunction of the PD mice. Although TMAO had no effect on the dopaminergic neurons, TH protein content, and striatal DA level in the PD mice, it significantly reduced the striatal 5-HT levels and aggravated the metabolism of DA and 5-HT. Meanwhile, TMAO significantly activated glial cells in the striatum and the hippocampi of the PD mice and promoted the release of inflammatory cytokines in the hippocampus. In summary, higher-circulating TMAO had adverse effects on the motor capacity, striatum neurotransmitters, and striatal and hippocampal neuroinflammation in PD mice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurodegeneration and Injury, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
Förderung
- The National Natural Science Foundation of China
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Quan, W., Qiao, C. M., Niu, G. Y., Wu, J., Zhao, L. P., Cui, C., Zhao, W. J., & Shen, Y. Q. (2023). Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease. Brain Sciences, 13(5), 790. https://doi.org/10.3390/brainsci13050790
Vancouver
Quan W, Qiao CM, Niu GY, Wu J, Zhao LP, Cui C, et al. Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease. Brain Sciences. 2023;13(5):790. doi:10.3390/brainsci13050790
BibTeX
@article{Quan2023,
author = {Quan, Wei and Qiao, Chen-Meng and Niu, Gu-Yu and Wu, Jian and Zhao, Li-Ping and Cui, Chun and Zhao, Wei-Jiang and Shen, Yan-Qin},
title = {Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease},
journal = {Brain Sciences},
year = {2023},
volume = {13},
number = {5},
pages = {790},
doi = {10.3390/brainsci13050790}
}
EUVIMED